Pancreas Allograft Thrombosis as a Post-COVID-19 Complication in a Diabetic Patient After Pancreas Transplantation.

Dear Editor,

The SARS-CoV-2 pandemic has caused a huge overload onthe healthcare system worldwide [1]. From March 4th 2020 until December, 7th 2021 the total number of COVID-19 cases in Poland reched 3,684,671 million. According to the Polish Ministry of Health 85,700 infected patients died, most of them had been suffering from concurrent disease. [2] The mortality rate from COVID-19 in Polish population is ~2.5%.

An increase of thrombotic and thromboembolic complications has been associated with COVID-19 in both arterial and venous systems. [3,4]

Patients after transplantation suffering from COVID-19 are at a higher risk of mortality (24–42%) and complications than the average population. [5] Recently, in our Center, there was a case of a PTA recipient with diabetes t1 that developed venous and arterial thrombosis 4 months after COVID-19, resulting in graft necrosis and finally in pancreas graftectomy (Figure 1A–1G). Our 6-year post-PTA patient had no history of thromboembolism or other risk factors apart from diabetes t 1 and a history of COVID-19. Earlier, in 2020 and 2021, 2 cases of infarction of a transplanted kidney in patients suffering from COVID-19 were described. Moreover, both cases occurred in obese transplant recipients with diabetes t 1. The first case – a man with DM t1 13 years after kidney and pancreas transplantation who had a segmental infarction of the kidney [6], and the second case was a woman with DM t1 6.5 months after kidney transplantation, who lost the graft as a result of a renal artery infarction. [7] Identifiable risk factors linking these cases are the post-transplant status for t1 diabetes and obesity.

Figure 1

(A–C) 3D vascular reconstructions of Computed Tomography. A, B – Arterial phase. C – Venous phase. The marks show the localization of pancreatic graft. It is not visible because of the absence of blood flow. (D–G) Images from gastroduodenoscopy. Marks show the necrosis of the mucosa of transplanted duodenum with central ulceration.

Conclusions

Transplant patients who have experienced COVID-19 should be carefully monitored for the occurrence of graft arterial and vein embolism. Early detection of these complications in patients after organ transplantation gives an opportunity to save the organ. Thromoprophylaxis with low molecular weight heparin is highly important and should be continued in high-risk patients (obese, with persistent d-dimer levels >1000) for a minimum of 2 weeks (preferably 4–6 weeks) after reaching the convalescent status.